Table 1.

The imaging capabilities of OCT in superficial tumors.

Cancer	Authors	Main Findings
Cutaneous melanoma	Von Knorring et al. (2022) (54); Schuh et al. (2022) (55)	OCT can distinguish benign and malignant pigmented cutaneous tumors
Cutaneous basal cell carcinoma	Gust et al. (2022) (56); Suppa M et al. (2021) (33); Verzì et al. (2021) (57)	LC-OCT can describe the characteristics of basal cell carcinoma at the bedside for differential diagnosis of basal cell carcinoma and for typing of basal cell carcinoma and assessment of response to treatment of BCC.
Squamous cell carcinoma of the skin	Ho et al. (2021) (35)	FF-OCT can provide fast, non-invasive, and accurate SCC classification with high accuracy.
Oral cancer	Yuan et al. (2022) (58); Trebing et al. (2021) (59); Ilhan et al. (2020) (60); Chen et al. (2020) (61)	OCT can assess structural changes in oral epithelial cells, distinguish oral cancer from precancerous lesion tissue, and conduct noninvasive screening, detection, evaluation of differentiation, and staging oral dysplasia and early cancer.